• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Briefing Information for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

FDA

Disclaimer

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).

FDA Briefing Information, Artesunate Rectal Suppositories, for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee (PDF – 696KB)

Errata to the FDA Briefing Information, Artesunate Rectal Suppositories, for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee (PDF – 35.6KB)

 

World Health Organization

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

WHO Briefing Information, Artesunate Rectal Suppositories, for the April 29, 2010 Meeting of the Anti-Infective Drugs Advisory Committee (PDF – 51.7KB)